Dr. Yuling Zou, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, china
Dr. Yuling Zou is a distinguished Medical Doctor (M.D.), Associate Chief Physician, and Master’s Supervisor at The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University. With extensive contributions to ophthalmology research, innovation, and education, she is recognized as a leading expert in retinal diseases, particularly in ferroptosis mechanisms and diabetic eye complications.
Profile
Scopus
Early Academic Pursuits
Dr. Zou earned her Ph.D. in Ophthalmology from the renowned Sun Yat-sen University Ophthalmology Center, a leading institution in vision research. Her early training emphasized deep academic rigor, where she developed foundational expertise in ocular pathology, cellular mechanisms of retinal degeneration, and translational medicine, setting the stage for her impactful career.
Professional Endeavors
Currently serving as Associate Chief Physician at the Nanchang University Affiliated Eye Hospital, Dr. Zou also holds roles in multiple provincial research and clinical centers, including the Jiangxi Key Laboratory of Ophthalmology and Vision Sciences and the Jiangxi Clinical Research Center for Ophthalmic Disease. She plays key roles in several professional organizations, including as Vice Chair of the Jiangxi Research Hospital Association–Ophthalmology Branch and Committee Member of both the Jiangxi Medical Association-Ophthalmology Society and Jiangxi Health Commission Expert Committee.
Contributions and Research Focus
Dr. Zou’s research is centered on retinal diseases such as diabetic retinopathy and age-related macular degeneration, with a cutting-edge focus on ferroptosis — a form of programmed cell death. Her landmark project, “Berberine Inhibits High Glucose-Induced Ferroptosis in Retinal Vascular Endothelial Cells”, has opened new therapeutic avenues in ocular pharmacology. She has also contributed to the pharmacological applications of berberine in ocular health, showcasing her innovation at the interface of traditional compounds and modern medicine.
Impact and Influence
With over 10 SCI-indexed publications and more than 47 citations, Dr. Zou’s work has been recognized for its clinical and scientific relevance. Her 6 ophthalmic patents have directly improved surgical precision and outcomes, and her involvement in 7 national and provincial research projects demonstrates her leadership in pushing the frontiers of ophthalmology in China.
Academic Citations and Research Skills
Dr. Zou’s publications have gained traction for their rigorous methodologies and clinical relevance, often cited in the fields of retinal biology and pharmaceutical interventions. Her expertise includes advanced cellular imaging, biochemical analysis of oxidative stress pathways, and drug efficacy studies, particularly in the context of retinal vascular pathology.
Teaching Experience
As a Master’s Supervisor, Dr. Zou has mentored over 12 postgraduate students, guiding them through both clinical practice and research innovation. Her mentorship emphasizes evidence-based medicine, experimental design, and critical thinking, making her a respected educator within the academic community.
Awards and Honors
Dr. Zou’s excellence has been recognized through prestigious honors such as the Jiangxi Outstanding Youth Fund and the “Ganpo Jun Cai” Talent Award. These awards underscore her outstanding scientific innovation, regional leadership, and contributions to youth mentorship in medicine.
Legacy and Future Contributions
Looking forward, Dr. Zou aims to expand her research into international collaborations, enhance the clinical applicability of ferroptosis inhibitors, and further develop patented surgical innovations. With a commitment to bridging basic science and clinical solutions, she is poised to leave a lasting legacy in ophthalmic innovation and contribute significantly to global vision health.
Top Publications
Intraocular fluid analysis-guided precision therapy in the treatment of acute retinal necrosis syndrome
-
Authors: Xiao Yu, Ziqing Mao, Yuling Zou, Yao Zhao, Huimin Fan, Teng Liu, Yiming Lei, Hua Zou, Zhipeng You
-
Journal: Scientific Reports
-
Year: 2025
Berberine inhibits high glucose-induced ferroptosis in retinal vascular endothelial cells: Mechanism and implications
-
Authors: Jia Chen, Wenxuan Peng, Wen Yang, Zhipeng You, Yuling Zou
-
Journal: Experimental Eye Research
-
Year: 2025